Exosomes in Nephropathies: A Rich Source of Novel Biomarkers

Dis Markers. 2020 Aug 12:2020:8897833. doi: 10.1155/2020/8897833. eCollection 2020.

Abstract

The biomarkers commonly utilized in diagnostic evaluations of kidney disease suffer from low sensitivity, especially in the early stages of renal damage. On the other hand, obtaining a renal biopsy to augment clinical decision making can lead to potentially serious complications. In order to overcome the shortcomings of currently available diagnostic tools, recent studies suggest that exosomes, cell-secreted extracellular vesicles containing a large array of active molecules to facilitate cell-to-cell communication, may represent a rich source of novel disease biomarkers. Because of their endocytic origin, exosomes carry markers typical for their parent cells, which could permit the localization of biochemical cellular alterations in specific kidney compartments. Different types of exosomes can be isolated from noninvasively obtained biofluids; however, in the context of kidney disease, evidence has emerged on the role of urinary exosomes in the diagnostic and predictive modeling of renal pathology. The current review summarizes the potential application of exosomes in the detection of acute and chronic inflammatory, metabolic, degenerative, and genetic renal diseases.

Publication types

  • Review

MeSH terms

  • Biomarkers / urine*
  • Clinical Decision-Making
  • Early Diagnosis
  • Exosomes / metabolism*
  • Humans
  • Kidney Diseases / diagnosis*
  • Kidney Diseases / metabolism
  • Kidney Diseases / urine
  • Urine / cytology

Substances

  • Biomarkers